The store will not work correctly when cookies are disabled.
4-(2,5-difluorophenyl)-5-(3-fluoro-4-(methylsulfonyl)phenyl)-2,2-dimethylfuran-3(2H)-one
ID: ALA3979155
PubChem CID: 18386097
Max Phase: Preclinical
Molecular Formula: C19H15F3O4S
Molecular Weight: 396.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC1(C)OC(c2ccc(S(C)(=O)=O)c(F)c2)=C(c2cc(F)ccc2F)C1=O
Standard InChI: InChI=1S/C19H15F3O4S/c1-19(2)18(23)16(12-9-11(20)5-6-13(12)21)17(26-19)10-4-7-15(14(22)8-10)27(3,24)25/h4-9H,1-3H3
Standard InChI Key: LKKHZCDZQZQBFX-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
37.1203 -20.9828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7158 -20.2771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3069 -20.9802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4056 -15.5733 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.3674 -16.3934 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
35.0967 -16.0164 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.0552 -19.8015 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.3786 -19.7952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1211 -19.0170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3048 -19.0246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1565 -20.0456 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.8216 -18.3675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1510 -17.6184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6672 -16.9607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8541 -17.0509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5272 -17.8045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0129 -18.4590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5936 -18.3551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4078 -18.4360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8831 -17.7722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5453 -17.0271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7275 -16.9499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2559 -17.6147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5567 -16.4851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9953 -16.2123 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
38.7449 -19.1804 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
37.3870 -16.2070 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
5 4 2 0
6 5 2 0
7 2 1 0
2 8 1 0
8 9 1 0
9 10 2 0
10 7 1 0
8 11 2 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
10 12 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
9 18 1 0
15 5 1 0
5 24 1 0
14 25 1 0
19 26 1 0
22 27 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 396.39 | Molecular Weight (Monoisotopic): 396.0643 | AlogP: 3.75 | #Rotatable Bonds: 3 |
Polar Surface Area: 60.44 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.46 | CX LogD: 3.46 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.79 | Np Likeness Score: -0.57 |
References
1. (2002) 4,5-diaryl-3(2H)-furanone derivatives as cyclooxygenase-2 inhibitors, |